FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016385757> ?p ?o ?g. }

• W2016385757 endingPage "694" @default.
• W2016385757 startingPage "689" @default.
• W2016385757 abstract "Tanshinone IIA (Tan IIA), one of the major active constituents of the medicinal herb Salvia miltiorrhiza, has been reported to possess neuroprotective effects against the pathological features of Alzheimer's disease (AD), but the molecular mechanism underlying this effect remains unclear. To examine the effect of Tan IIA on AD, as well as the underlying molecular mechanisms, in vivo animal experiments and in vitro molecular biology investigations were employed in the present study. Firstly, a rat model of AD was successfully established by direct injection of the amyloid beta protein (Aβ) and then these rats were administered an interventional treatment of Tan IIA. The learning and memory ability of rats was evaluated in four groups (Control, Sham, AD and Tan IIA) utilizing a Morris water maze test. Quantitative (q)PCR was employed to detect the mRNA expression of inducible nitric oxide synthase (iNOS), matrix metalloproteinase‑2 (MMP‑2) and nuclear transcription factor kappa (NF‑κBp65) in temporal lobe tissues and protein expression was determined with western blot analysis. In addition, association analyses between iNOS, MMP‑2 and NF‑κBp65 at a transcriptional and translational level were performed utilizing Spearman's correlation analysis. In the present study, the results revealed that rats in the AD group demonstrated significant disruptions in learning and memory ability, and the symptoms were evidently reduced by Tan IIA. Furthermore, the upregulation of iNOS, MMP‑2 and NF‑κBp65 at a transcriptional and translational level in AD rats was distinctly inhibited by Tan IIA. Therefore, it was concluded that iNOS, MMP‑2 and NF‑κBp65 are involved in AD development, and Tan IIA may reduce AD risk by inhibiting transcription and translation of these genes. Furthermore, the positive correlation of iNOS and MMP‑2 with NF‑κBp65, respectively, provides evidence supporting the hypothesis that Tan IIA reduces AD risk by inhibiting iNOS and MMP‑2 at a transcriptional and translational level through the NF‑κB pathway. In summary, Tan IIA is an effective neuroprotective agent for AD therapy, and iNOS, MMP‑2 and NF‑κBp65 may be the potential molecular targets for manipulating this effect therapeutically." @default.
• W2016385757 created "2016-06-24" @default.
• W2016385757 creator A5012635551 @default.
• W2016385757 creator A5066870388 @default.
• W2016385757 creator A5068765890 @default.
• W2016385757 creator A5084907875 @default.
• W2016385757 date "2014-05-20" @default.
• W2016385757 modified "2023-10-16" @default.
• W2016385757 title "Tanshinone IIA reduces the risk of Alzheimer’s disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s disease" @default.
• W2016385757 cites W1690235847 @default.
• W2016385757 cites W1978164136 @default.
• W2016385757 cites W1992556352 @default.
• W2016385757 cites W2023973572 @default.
• W2016385757 cites W2035516871 @default.
• W2016385757 cites W2055270900 @default.
• W2016385757 cites W2057047384 @default.
• W2016385757 cites W2059013170 @default.
• W2016385757 cites W2063887943 @default.
• W2016385757 cites W2068267549 @default.
• W2016385757 cites W2075804010 @default.
• W2016385757 cites W2075830408 @default.
• W2016385757 cites W2106218976 @default.
• W2016385757 cites W2108451686 @default.
• W2016385757 cites W2124054487 @default.
• W2016385757 cites W2152299618 @default.
• W2016385757 cites W2217220234 @default.
• W2016385757 cites W2285449497 @default.
• W2016385757 doi "https://doi.org/10.3892/mmr.2014.2254" @default.
• W2016385757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24859152" @default.
• W2016385757 hasPublicationYear "2014" @default.
• W2016385757 type Work @default.
• W2016385757 sameAs 2016385757 @default.
• W2016385757 citedByCount "65" @default.
• W2016385757 countsByYear W20163857572012 @default.
• W2016385757 countsByYear W20163857572015 @default.
• W2016385757 countsByYear W20163857572016 @default.
• W2016385757 countsByYear W20163857572017 @default.
• W2016385757 countsByYear W20163857572018 @default.
• W2016385757 countsByYear W20163857572019 @default.
• W2016385757 countsByYear W20163857572020 @default.
• W2016385757 countsByYear W20163857572021 @default.
• W2016385757 countsByYear W20163857572022 @default.
• W2016385757 countsByYear W20163857572023 @default.
• W2016385757 crossrefType "journal-article" @default.
• W2016385757 hasAuthorship W2016385757A5012635551 @default.
• W2016385757 hasAuthorship W2016385757A5066870388 @default.
• W2016385757 hasAuthorship W2016385757A5068765890 @default.
• W2016385757 hasAuthorship W2016385757A5084907875 @default.
• W2016385757 hasBestOaLocation W20163857571 @default.
• W2016385757 hasConcept C104317684 @default.
• W2016385757 hasConcept C127561419 @default.
• W2016385757 hasConcept C134018914 @default.
• W2016385757 hasConcept C142724271 @default.
• W2016385757 hasConcept C185592680 @default.
• W2016385757 hasConcept C188947578 @default.
• W2016385757 hasConcept C204787440 @default.
• W2016385757 hasConcept C25498285 @default.
• W2016385757 hasConcept C2776332195 @default.
• W2016385757 hasConcept C2776415932 @default.
• W2016385757 hasConcept C2777622882 @default.
• W2016385757 hasConcept C2781161787 @default.
• W2016385757 hasConcept C44752575 @default.
• W2016385757 hasConcept C519581460 @default.
• W2016385757 hasConcept C55493867 @default.
• W2016385757 hasConcept C71924100 @default.
• W2016385757 hasConcept C86803240 @default.
• W2016385757 hasConcept C98274493 @default.
• W2016385757 hasConceptScore W2016385757C104317684 @default.
• W2016385757 hasConceptScore W2016385757C127561419 @default.
• W2016385757 hasConceptScore W2016385757C134018914 @default.
• W2016385757 hasConceptScore W2016385757C142724271 @default.
• W2016385757 hasConceptScore W2016385757C185592680 @default.
• W2016385757 hasConceptScore W2016385757C188947578 @default.
• W2016385757 hasConceptScore W2016385757C204787440 @default.
• W2016385757 hasConceptScore W2016385757C25498285 @default.
• W2016385757 hasConceptScore W2016385757C2776332195 @default.
• W2016385757 hasConceptScore W2016385757C2776415932 @default.
• W2016385757 hasConceptScore W2016385757C2777622882 @default.
• W2016385757 hasConceptScore W2016385757C2781161787 @default.
• W2016385757 hasConceptScore W2016385757C44752575 @default.
• W2016385757 hasConceptScore W2016385757C519581460 @default.
• W2016385757 hasConceptScore W2016385757C55493867 @default.
• W2016385757 hasConceptScore W2016385757C71924100 @default.
• W2016385757 hasConceptScore W2016385757C86803240 @default.
• W2016385757 hasConceptScore W2016385757C98274493 @default.
• W2016385757 hasIssue "2" @default.
• W2016385757 hasLocation W20163857571 @default.
• W2016385757 hasLocation W20163857572 @default.
• W2016385757 hasOpenAccess W2016385757 @default.
• W2016385757 hasPrimaryLocation W20163857571 @default.
• W2016385757 hasRelatedWork W2010868322 @default.
• W2016385757 hasRelatedWork W2039674246 @default.
• W2016385757 hasRelatedWork W2055462428 @default.
• W2016385757 hasRelatedWork W2057619175 @default.
• W2016385757 hasRelatedWork W2247275781 @default.
• W2016385757 hasRelatedWork W2282695454 @default.
• W2016385757 hasRelatedWork W2338316433 @default.
• W2016385757 hasRelatedWork W2364426760 @default.

• next